| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers H > Headlines for Hypertension Diagnostics, Inc. > News item |
Hypertension Diagnostics extends expiry on warrants connected to 2003 PIPE
By Sheri Kasprzak
New York, May 22 - Hypertension Diagnostics, Inc. has extended the expiry on warrants for common shares and series A convertible preferred stock issued in an August 2003 private placement.
The expiry on B warrants for 23,297,213 common shares was extended to June 23 from May 19 and the expiry on B warrants for 1,464,975 series A preferred shares was also extended to June 23 from May 19.
The common share warrants are exercisable at $0.22 each and the series A preferred warrants are exercisable at $2.64 each.
In the placement, Hypertension Diagnostics sold $2.3 million in units of 9,318,866 common shares and 585,980 series A preferreds that pay annual dividends at 11%, as well as the warrants.
Hypertension Diagnostics is an Eagan, Minn., maker of blood pressure waveform analysis equipment.
Hypertension's stock gained 2 cents, or 6.67%, to end at $0.32 (OTCBB: HDII).
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.